Margareta Spjut
@Healthinvest Partners Ab
Latest period2024 - Q3ReportedManaged Assets$212.751MTotal holdings36
Assets growth rate29.73%Assets growth rate (2-Q avg)14.76%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Healthinvest Partners Ab's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 36 positions.
Assets under management
The assets under management (AUM) of Healthinvest Partners Ab over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 212.751M in assets, with a quarterly growth rate of 29.73% and a 2-quarter average growth rate of 14.76%. The portfolio is managed by Margareta Spjut, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
MRUSMerus N V
| 1.2% | $2.532M 50,687 shares@ $49.97 avg price | Increased 64.38% |
NAMSNewamsterdam Pharma Company
| 1.09% | $2.307M 138,983 shares@ $16.61 avg price | Increased 83.37% |
IMCRImmunocore Hldgs Plc
| 0.8% | $1.683M 54,060 shares@ $31.14 avg price | Increased 127.36% |
KRYSKrystal Biotech Inc
| 0.79% | $1.675M 9,202 shares@ $182.03 avg price | Increased 20.7% |
AUTLAutolus Therapeutics Plc
| 0.76% | $1.606M 442,423 shares@ $3.63 avg price | Increased 95.64% |
CRBPCorbus Pharmaceuticals Hldgs
| 0.68% | $1.435M 69,573 shares@ $20.64 avg price | Increased 77.94% |
MRSNMersana Therapeutics Inc
| 0.48% | $1.018M 538,621 shares@ $1.9 avg price | Increased 191.31% |
CABACabaletta Bio Inc
| 0.38% | $795,424 168,522 shares@ $4.73 avg price | Increased 162.01% |